Literature DB >> 6698661

The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.

U Täuber, D Haack, B Nieuweboer, G Kloss, P Vecsei, H Wendt.   

Abstract

The pharmacokinetics of fluocortolone and of prednisolone were examined following a single intravenous injection of 5 mg and oral administrations of 10 and 20 mg to five healthy male volunteers. After intravenous injection the plasma levels of fluocortolone decreased biexponentially with half-lives of 9 +/- 5 min and 1.3 +/- 0.3 h. Total plasma clearance of fluocortolone was calculated to be 7.0 +/- 1.5 ml/min/kg. Oral administrations of fluocortolone revealed maximum plasma levels of 86 +/- 12 ng/ml (10-mg dose) and 174 +/- 34 ng/ml (20-mg dose) after 1.4 +/- 0.2 h. Intravenously administered prednisolone was rapidly distributed (t 1/2 alpha = 5 +/- 3 min) but more slowly eliminated from plasma than fluocortolone (t1/2 beta = 3.1 +/- 0.8 h). Correspondingly a total plasma clearance of 2.2 +/- 0.2 ml/min/kg was calculated. Oral administrations revealed maximum prednisolone plasma levels of 172 +/- 25 ng/ml (10-mg dose) and 278 ng/ml (20-mg dose) after 1.6 +/- 0.7 h. The absolute bioavailability of both corticosteroids was higher than 80% and independent of both dose levels investigated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698661

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  7 in total

Review 1.  Systems dynamics in clinical pharmacokinetics. An introduction.

Authors:  J M van Rossum; J E de Bie
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

2.  Pharmacokinetics of fluocortolone in man.

Authors:  U F Legler
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Dose-dependent pharmacokinetics of dexamethasone.

Authors:  D Loew; O Schuster; E H Graul
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Lack of impairment of fluocortolone disposition in oral contraceptive users.

Authors:  U F Legler
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Adrenocortical responsiveness after discontinuous corticosteroid therapy.

Authors:  P Beris; A Burger; L Favre; A Riondel; P A Miescher
Journal:  Klin Wochenschr       Date:  1986-01-15

6.  Fluocortolone: pharmacokinetics and effect on ACTH and cortisol secretion during daily and alternate-day administration.

Authors:  U Tüber; U Posern; U Bickel; H Matthes; K Voigt
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Fluocortolone: pharmacokinetics and effect on plasma cortisol level.

Authors:  U Täuber; K Richter; H Matthes
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.